Amid spurt in black fungus cases, crucial drug out of stock in Bengaluru

Some private hospitals, which have operated upon CAM patients are frantically looking for Amphotericin-B and even calling government and government hospitals for some vials.

Published: 21st May 2021 05:25 AM  |   Last Updated: 21st May 2021 05:25 AM   |  A+A-

Black fungus

A magnified scan of Black fungus. (Representational Image)

Express News Service

BENGALURU: There has been an “exponential” increase in cases of Covid-Associated Mucormycosis (CAM), or black fungus, in Bengaluru over the last 10 days, but the all-importantanti- fungal drug Liposomal Amphotericin or Amphotericin- B has surprisingly gone out of stock! In its absence, some hospitals are either using other alternative drugs, which may not be as effective as Amphotericin-B or are using plain Amphotericin, which is nephro-toxic and has the potential to damage kidneys.

Some private hospitals, which have operated upon CAM patients are frantically looking for Amphotericin-B and even calling government and government hospitals for some vials. “Amphotericin- B was easily available in the market till recently. It is not available now,” said Medical Director of Sri Bhagwan Mahaveer Jain Hospital, MD Marker.

“There is an increase in CAM cases and we urgently require Amphotericin- B,” he added. “Liposomal Amphotericin enables us to use higher doses without the toxicity associated with plain Amphotericin. Higher doses ensure better and quicker eradication of the fungus. Unfortunately, the supply of Amphotericin- B is inadequate, given the current demand.

The only option left is to improve immunity with better control of diabetes and removal of dead tissue from the nose and sinuses to lower the fungal load and use second line drugs like Posaconazole or Isavuconazole.

This has to be done at the earliest to prevent the spread to the eyes, resulting in loss of vision, and spread to the brain, which can result in loss of life,” said Dr E V Raman, consultant ENT specialist, Manipal Hospital, Old Airport Road. Dr Athira Ramakrishnan, consultant ENT specialist, Fortis Hospital, Bannerghatta Road, also admitted that there was a “shortage of Amphotericin- B due to the sudden surge in the number of cases.”

State forms CAM Task Force on black fungus

“In normal circumstances, a busy tertiary referral centre sees around 12 to 15 cases in a year, so the medication is stocked accordingly. Amphotericin is the first choice of medication.

There are other antifungal medications like Posaconazole, Isavuconazole that can be used as alternatives, but they may not be as effective as Amphotericin-B,” Dr Athira Ramakrishnan said.

“There has been a significant rise in Mucormycosis cases and it mostly affects the lungs and sinuses because of the use of steroids, inadequate monitoring of blood sugar level, altered innate immunity, invasion of vessels and formation of clots.,” said Dr Girish Anand, consultant ENT specialist Aster CMI Hospital, Hebbal. Many messages have also been circulating on social media platforms inquiring about the availability of the drug.

The State Government has formed a CAM Task Force and the Centre, after notifying it as an epidemic, on Thursday said that the shortage of Amphotericin B will be resolved. Its production has been ramped up by the existing six companies and five more firms have received approval for producing it in India. Union Minister Mansukh Mandaviya tweeted that Indian firms have placed orders for importing 6 lakh vials of Amphotericin-B.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp